MGTX - MeiraGTx Holdings plc
IEX Last Trade
4.08
-0.100 -2.451%
Share volume: 108,952
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.18
-0.10
-2.39%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-14 | 2023-05-11 | 2023-08-10 | 2023-11-14 | 2024-03-15 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 252.461 M | 301.412 M | 318.237 M | 288.140 M | 310.263 M | 267.194 M | 326.744 M | 309.235 M | |
| Current Assets | 104.412 M | 155.036 M | 154.339 M | 121.481 M | 143.144 M | 103.531 M | 159.622 M | 149.300 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 16.362 M | 16.629 M | 17.489 M | 16.399 M | 17.681 M | 17.768 M | 19.918 M | 19.179 M | |
| Short Term Investments | 16.362 M | 16.629 M | 17.489 M | 16.399 M | 17.681 M | 17.768 M | 19.918 M | 19.179 M | |
| Total Receivables | 15.942 M | 23.701 M | 21.334 M | 36.298 M | 32.690 M | 22.398 M | 10.138 M | 10.915 M | |
| Current Cash | 72.108 M | 114.706 M | 115.516 M | 68.784 M | 92.773 M | 63.365 M | 129.566 M | 119.206 M | |
| Total Non-current Assets | 148.049 M | 146.376 M | 163.898 M | 166.659 M | 167.119 M | 163.663 M | 167.122 M | 159.935 M | |
| Property Plant Equipment | 91.388 M | 93.620 M | 109.266 M | 112.580 M | 114.004 M | 111.880 M | 115.896 M | 111.412 M | |
| Other Assets | 47.808 M | 44.125 M | 46.229 M | 45.706 M | 44.784 M | 42.547 M | 42.259 M | 39.660 M | |
| Intangible Assets | 2.197 M | 1.975 M | 2.077 M | 2.047 M | 2.005 M | 1.872 M | 1.118 M | 1.038 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 252.461 M | 301.412 M | 318.237 M | 288.140 M | 310.263 M | 267.194 M | 326.744 M | 309.235 M | |
| Total liabilities | 110.489 M | 178.742 M | 200.499 M | 197.918 M | 186.736 M | 175.308 M | 188.567 M | 187.501 M | |
| Total current liabilities | 67.505 M | 72.363 M | 82.072 M | 81.104 M | 71.803 M | 63.514 M | 67.078 M | 47.543 M | |
| Accounts Payable | 18.111 M | 21.693 M | 16.616 M | 29.755 M | 28.497 M | 20.773 M | 16.042 M | 21.223 M | |
| Other liabilities | 23.740 M | 17.905 M | 29.877 M | 28.871 M | 27.665 M | 25.510 M | 36.418 M | 55.771 M | |
| Current long term debt | 3.634 M | 3.659 M | 3.884 M | 4.018 M | 4.126 M | 4.092 M | 4.193 M | 4.188 M | |
| Long term debt | 19.063 M | 88.303 M | 88.364 M | 87.754 M | 87.079 M | 86.100 M | 85.071 M | 84.187 M | |
| Other liabilities | 23.740 M | 17.905 M | 29.877 M | 28.871 M | 27.665 M | 25.510 M | 36.418 M | 55.771 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 141.972 M | 122.670 M | 117.738 M | 90.222 M | 123.527 M | 91.886 M | 138.177 M | 121.734 M | |
| Common stock | 44.668 M | 44.688 M | 46.854 M | 48.638 M | 55.350 M | 59.527 M | 62.432 M | 64.066 M | |
| Retained earnings | -405.607 M | -442.891 M | -470.204 M | -500.568 M | -530.149 M | -574.446 M | -554.231 M | -574.673 M |